ADVFN US – Market Content Editor
-
BioVie Shares Fall 9.7% After Long COVID Trial Misses Statistical Significance in Full Population
BioVie (NASDAQ:BIVI) shares fell nearly 9.7% in premarket trading after the company reported results from its Phase 2 ADDRESS-LC trial evaluating bezisterim for neurological symptoms associated with Long COVID. The study did not achieve statistical significance on any of its 22 clinical outcome measures in the full intent-to-treat population of 203 patients. The trial was…
-
Aeluma Shares Rise 7% After Sumitomo Chemical Photonics Manufacturing Agreement
Aeluma (NASDAQ:ALMU) shares rose 7% to $13.42 in premarket trading on Tuesday after the company announced an agreement with Sumitomo Chemical Advanced Technologies to jointly develop and manufacture photonics wafers for the artificial intelligence data communications market. Under the agreement, the companies will use Sumitomo Chemical Advanced Technologies’ existing metal-organic chemical vapour deposition, or MOCVD,…
-
BlossomHill Therapeutics Shares Rise 4.4% After BH-30643 Trial Update
BlossomHill Therapeutics (NASDAQ:BLSM) shares rose 4.4% in premarket trading after the company presented updated clinical data for investigational drug BH-30643 at the 2026 World Conference on Lung Cancer in Seoul, South Korea. The data came from the Phase 1/2 SOLARA trial evaluating BH-30643 in patients with EGFR C797S-positive non-small cell lung cancer, or NSCLC. Among…
-
Flex Shares Rise 2.6% as Company Names Planned Axiom Solutions Spin-Off
Flex (NASDAQ:FLEX) shares rose 2.6% in premarket trading after the company named its planned cloud and power infrastructure spin-off Axiom Solutions International and filed a preliminary Form 10 registration statement with the US Securities and Exchange Commission. The filing represents another step in Flex’s previously announced separation plan. The transaction is expected to be completed…
-
Micron Demonstrates 512GB DDR5 Memory Module for Server Platforms
Micron Technology (NASDAQ:MU) announced on September 15, 2026, that it has demonstrated a 512GB DDR5 registered dual in-line memory module, or RDIMM, across multiple server platforms. The company described the 512GB DDR5 RDIMM as the first module of its kind. It uses vertical interconnect packaging technology that stacks DRAM dies connected through through-silicon vias, or…
-
Zoom Launches AI-Powered Revenue Platform With New Sales and Forecasting Tools
Zoom Communications (NASDAQ:ZM) announced an AI-powered revenue operating system on September 15, 2026, aimed at bringing buyer intelligence, customer conversations and revenue-management tools into a single platform. The company introduced two capabilities for its Zoom Revenue Accelerator product, called Engage and Forecast. Engage allows sales teams to create multichannel sales sequences across email, phone and…
-
Curaleaf Urges Aurora Cannabis Shareholders to Tender Shares to Takeover Offer
Curaleaf Holdings (USOTC:CURLF) has sent a letter to Aurora Cannabis (NASDAQ:ACB) shareholders urging them to tender their shares to its outstanding acquisition offer after Aurora’s board declined to engage with the proposal. Under the offer, Aurora shareholders would receive 0.3463 Curaleaf shares and $0.75 in cash for each Aurora share. Curaleaf said the terms implied…
-
Forgent Power Solutions Shares Rise 10.9% After FY26 Results
Forgent Power Solutions (NYSE:FPS) shares rose 10.9% in premarket trading on Tuesday after the company released its fiscal fourth-quarter and full-year 2026 financial results. The results cover the period ended June 30, 2026. Forgent scheduled a conference call for 11:00 a.m. ET to discuss its financial performance and outlook. The supplied information did not include…
-
Vera Therapeutics Shares Rise 13% After TRUTAKNA Meets ORIGIN 3 Trial Endpoints
Vera Therapeutics (NASDAQ:VERA) shares rose 13% on Tuesday after the company reported that TRUTAKNA (atacicept-vymj) met all prespecified endpoints in the final efficacy analysis of its ORIGIN 3 trial in adults with primary IgA nephropathy. The company said the results showed that TRUTAKNA stabilised estimated glomerular filtration rate, or eGFR, and reduced kidney disease progression…
-
Axon Enterprise Shares Fall 5% After $1 Billion Convertible Notes Offering Announced
Axon Enterprise (NASDAQ:AXON) shares fell 5% on Tuesday after the public safety technology company announced plans to offer $1 billion of 0% convertible senior notes due 2031. The notes will be offered through a public offering registered under the Securities Act of 1933. Axon also expects to grant the underwriters an option to purchase up…